Valuation: Hypera S.A.

Market Cap 14.89B 2.87B 2.52B 2.32B 2.17B 4.08B 272B 4.15B 27.85B 10.81B 134B 10.8B 10.55B 467B P/E 2026 *
7.91x
P/E 2027 * 6.57x
Enterprise Value 20.97B 4.05B 3.54B 3.27B 3.05B 5.75B 383B 5.85B 39.23B 15.23B 189B 15.21B 14.87B 658B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.04x
Free-Float
38.88%
Yield 2026 *
5.35%
Yield 2027 * 5.74%
1 day-2.27%
1 week+0.30%
1 month-5.46%
3 months-5.46%
6 months-0.60%
Current year-0.60%
1 week 4
Extreme 4
4.29
1 month 3.8
Extreme 3.8
4.33
Current year 3.8
Extreme 3.8
5.5
1 year 3.71
Extreme 3.71
5.5
3 years 2.64
Extreme 2.64
10.08
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 50 2019-04-23
Director of Finance/CFO 38 2022-02-23
Chief Operating Officer 40 2019-12-31
Director TitleAgeSince
Director/Board Member 77 2007-05-31
Director/Board Member 60 2007-05-31
Director/Board Member 52 2007-03-25
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%+0.30% - - 2.87B
-2.48%+8.34%+53.87%+155.75% 1,097B
-1.76%+6.23%+66.27%+53.44% 622B
-1.05%+7.19%+35.57%+86.77% 449B
+0.83%+4.18%+31.11%+23.88% 334B
-1.38%+3.75%+39.33%+25.04% 294B
+0.30%+2.56%+31.62%+40.64% 286B
-0.10%+2.23%-28.43%-42.77% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.72%+5.61%+30.33%+52.20% 405.19B
Weighted average by Cap. -1.12%+7.04%+40.91%+77.66%

Financials

2026 *2027 *
Net sales 9.23B 1.78B 1.56B 1.44B 1.34B 2.53B 168B 2.57B 17.26B 6.7B 83.1B 6.69B 6.54B 290B 9.97B 1.92B 1.68B 1.56B 1.45B 2.73B 182B 2.78B 18.66B 7.24B 89.81B 7.23B 7.07B 313B
Net income 1.87B 361M 316M 292M 272M 513M 34.18B 523M 3.5B 1.36B 16.87B 1.36B 1.33B 58.76B 2.26B 437M 382M 353M 329M 620M 41.27B 631M 4.23B 1.64B 20.37B 1.64B 1.6B 70.95B
Net Debt 6.08B 1.17B 1.03B 949M 885M 1.67B 111B 1.7B 11.38B 4.42B 54.8B 4.41B 4.31B 191B 5.48B 1.06B 926M 855M 798M 1.5B 100B 1.53B 10.26B 3.98B 49.38B 3.98B 3.89B 172B
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
26-06-30 US$4.113 -2.27% 736
26-06-29 US$4.208 +2.38% 4,141
26-06-26 US$4.110 -0.48% 2,096
26-06-25 US$4.130 -0.48% 7,870
26-06-24 US$4.150 +1.22% 62,405
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
20.81BRL
Average target price
29.71BRL
Spread / Average Target
+42.79%

Quarterly revenue - Rate of surprise